Cargando…
The Effectiveness of the Rectal Administration of Low-dose Diclofenac for the Prevention of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis
OBJECTIVE: A 50-100-mg rectal dose of nonsteroidal anti-inflammatory drugs (NSAIDs; diclofenac or indomethacin) has been shown to prevent post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP). However, this is higher than the recommended 25-mg dose that is commonly administer...
Autores principales: | Okuno, Mitsuru, Shiroko, Junko, Taguchi, Daisuke, Yamaguchi, Kimihiro, Takada, Jun, Imai, Susumu, Sato, Hiroyuki, Thanabashi, Shinobu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148161/ https://www.ncbi.nlm.nih.gov/pubmed/29607957 http://dx.doi.org/10.2169/internalmedicine.0554-17 |
Ejemplares similares
-
Optimal timing of rectal diclofenac in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis
por: Sperna Weiland, Christina J., et al.
Publicado: (2022) -
Rectal indomethacin and diclofenac are equally efficient in preventing pancreatitis following endoscopic retrograde cholangiopancreatography in average‐risk patients
por: Yu, Shuang, et al.
Publicado: (2021) -
The safety and efficacy of Ringer's solution loading with rectal diclofenac for prevention of post‐endoscopic retrograde cholangiopancreatography pancreatitis: The RESOLUTION‐PEP study
por: Hattori, Aiji, et al.
Publicado: (2023) -
Role of Rectal Diclofenac Suppository for Prevention and Its Impact on Severity of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis in High-Risk Patients
por: Patil, Sandeep, et al.
Publicado: (2016) -
Rectal versus intramuscular diclofenac in prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: experience of a Greek tertiary referral center
por: Kalantzis, Ioannis, et al.
Publicado: (2020)